Login Register Cart 0
Generic placeholder image

Current Traditional Medicine

Editor-in-Chief

ISSN (Print): 2215-0838
ISSN (Online): 2215-0846

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

An In-depth Analysis of Majoon Zabeeb, an Enduring Polyherbal Unani Formulation for Epilepsy

Author(s): Md. Aftab Alam, Mohammad Zakir*, Faiza Khatoon, Waish Ahmad and Ahmed Minhajuddin

Volume 9, Issue 4, 2023

Published on: 18 October, 2022

Article ID: e140922208822 Pages: 7

DOI: 10.2174/2215083808666220914114945

Price: $65

Abstract

Unani Medicine System is one of the oldest systems, with its potent and effective drugs from animal, plant, and mineral sources. Over 2400 years ago, Hippocrates, the founder of medicine, practiced it; however, his medicine includes many ancient Egyptian medications and important components of ancient Mesopotamian customs and traditions. Neurological problems are a significant cause of death, comprising 12% of all deaths globally. Sar' is used for epilepsy in USM, which means falling. Convulsions occur after the patient has fallen due to partial occlusion in the passage of Rūh Nafsānī (psychic pneuma).

A vast number of single and multi-ingredient medicines were referenced for epilepsy treatment. Majoon Zabeeb (MZ) is possibly the most presumed polyherbal preparation used in epilepsy. This polyherbal compound has eight components used as a strong anticonvulsant, antispasmodic, antioxidant, deobstruent, memory enhancer, neuroprotective, nervine tonic, and anti-inflammatory agent.

Keywords: Anticonvulsant, Neurological disorder, Majoon Zabeeb, Sar ', Unani medicine

Graphical Abstract

[1]
Abu Asbab M, Amri H, Micozzi MS. Avicenna’s Medicine- a new translation of the 11th-century canon with practical applications for integrative health care. Vermont: Healing Press 2013; p. 69.
[2]
Ravishankar B, Shukla VJ. Indian systems of medicine: A brief profile. Afr J Tradit Complement Altern Med 2008; 4(3): 319-37.
[http://dx.doi.org/10.4314/ajtcam.v4i3.31226] [PMID: 20161896]
[3]
Lone AH, Ahmad T, Anwar M, Sofi G, Imam H, Habib S. Perception of health promotion in Unani herbal medicine. J Herb Med 2012; 2(1): 1-5.
[http://dx.doi.org/10.1016/j.hermed.2012.02.003]
[4]
Ahmad B, Akhtar J. Unani system of medicine. Pharmacogn Rev 2007; 1(2): 210.
[5]
Tarun D, Aleksandar J, Anna M. Neurological disorders: Public health challenges. Geneva: World Health Organization 2006. Available from: https://www.worldcat.org/formats-editions/122438264
[6]
Gorji A, Khaleghi Ghadiri M. History of epilepsy in Medieval Iranian medicine. Neurosci Biobehav Rev 2001; 25(5): 455-61.
[http://dx.doi.org/10.1016/S0149-7634(01)00025-2] [PMID: 11566482]
[7]
Anonymous . World health organization epilepsy Available from: https://www.who.int/news-room/fact-sheets/detail/epilepsy [accessed on 21 June 2021 at 11:50 PM]
[8]
Sina Ibn. Al-Qanoon fi’l-Tibb. New Delhi. Jamia Hamdard. 1990; III: pp. 114-23.
[9]
Zuhr I. Kitab al-Taysir fi’l-Mudawa wa-al-Tadbeer (Urdu Translation), Central Council for Research in Unani Medicine. New Delhi: CCRUM 1986; p. 55.
[10]
Razi MBZ. Kitab al-Hawi, Volume I (Urdu Translation). New Delhi: Central Council for Research in Unani Medicine (CCRUM) 1997; pp. 106-30.
[11]
Qamri AMH. Ghina Muna (Arabic), Central Council for Research in Unani Medicine. New Delhi: CCRUM 2008; pp. 18-24.
[12]
Wahab A. Difficulties in treatment and management of epilepsy and challenges in new drug development. Pharmaceuticals (Basel) 2010; 3(7): 2090-110.
[http://dx.doi.org/10.3390/ph3072090] [PMID: 27713344]
[13]
Kamboj VP. Herbal medicine. Curr Sci 2000; 78(1): 35-9.
[14]
Afrin Z, Siddiqui A, Jafri MA, Asif M, Jahan H. Majoon najah: A potent Unani formulation for neurological disorders. Euro J Biomed Pharm Sci 2011; 4(7): 198-206.
[15]
Khan MA. Iksir-e-Azam, Volume II, (Persian). Lucknow: Matba Nami Nawal Kishor 1906; pp. 238-65.
[16]
Iwaz NB. Sharah al-Asbab wa-al-Alamat, part I (Arabic). Lucknow. Matba Nami Munshi Naval Kishor. 2006; 1326H: pp. 86-7.
[17]
Kabiruddin MH. Al-Qarabadeen. New Delhi: Central Council for Research in Unani Medicine 2006; p. 1139.
[18]
Kabiruddin MH. Bayaz-i Kabir, Volume-II, Central Council for Research in Unani Medicine. New Delhi: CCRUM 2008; p. 183.
[19]
Anonymous . National Formulary of Unani medicine Part 1, Volume-1. New Delhi: Ministry of Health and Family Welfare, Dept. of AYUSH 2006; p. 146-, 312-314, 331-332.
[20]
Anonymous . Physicochemical standardization of Unani formulations Part-3 Central Council for Research in Unani Medicine. New Delhi: CCRUM 1991; pp. 122-4.
[21]
Lateef A. Qarabadeen-e-Majeedi. 9th ed In: All India Unani Tibbi Conference. New Delhi 1986; pp. 366-7.
[22]
Ali E. Qarabadeen-e-Ehsani (Urdu translation). (2nd ed.). New Delhi: Ministry of Health and Family Welfare, Dept. of AYUSH, Govt. of India 2006; p. 130.
[23]
Arzani A. Qarabadeen Qadri, Central Council for Research in Unani Medicine. New Delhi: CCRUM 2009; p. 90.
[24]
Khan A. Qarabadeen Azam Central Council for Research in Unani Medicine. New Delhi: CCRUM 2009; p. 457.
[25]
Khare CP. Indian Medicinal Plants: An Illustrated DictionaryBerlin. Springer Verlag 2007; pp. 46-7.
[26]
Nadkarni KM. Indian Materia Medica. Mumbai: Popular Prakashan 1976; pp. 97-8.
[27]
Hakeem MA, Al Mufradat B. Idara Kitabus Shifa. New Delhi 2002; pp. 67-8.
[28]
Kabiruddin MH. Makhznul Mufradat Al Maroof Khawasul Advia. Deoband. Faisal Publication. 2000; 55: pp. 74-75l.
[29]
Anonymous . Standard Unani medical terminology, Central Council for Research in Unani Medicine. New Delhi: CCRUM 2012; p. 123.
[30]
Chaudhary SS, Tariq M, Zaman R, Shaikh I. Solid dosage forms in the Unani system of medicine. JPSI 2013; 2(3): 17-22.
[http://dx.doi.org/10.7897/2277-4572.02325]
[31]
Anonymous . Unani pharmacopoeia of India Part 11, Volume-1. New Delhi: Ministry of Health and Family Welfare, Dept. of A YUSH 2009; pp. 269-270, 280.
[32]
Iqbal B, Khan NA. Standardization of a non Pharmacopoeial Majoon used in Unani medicine. Int J Adv Pharm Med Bioallied Sci 2015; 3(1): 18-21.
[33]
Antaki DZ. Tajkiratu Ulil Albaab Wal Jame Lil Ajabil Ujaab, Part I Misr. Al-Matba Atul Aamiratus Saqafiyah 1899; pp. 40-1.
[34]
Choghtai GM, Choghtai F. Bayaz-e-Ferozi. Lahore; Sheikh Muhammad Basheer & Sons: YNM, 163.
[35]
Kanagarla NA, Kuppast IJ, Veerashekar T, Reddy CL. A review on benefits and uses of Vitis vinifera (Grape). RRBS 2013; 7(5): 175-80.
[36]
Debnath J, Sharma UR, Kumar B, Chauhan NS. Anticonvulsant activity of ethanolic extract of fruits of Terminalia chebula on experimental animals. IJDDR 2010; 2(4): 764-8.
[37]
Khan MU, Khalilullah HA, Akhtar JA, Elhasan GO. Terminalia chebula: An ephemeral glance. Int J Pharm Pharm Sci 2015; 7(2): 40-3.
[38]
Chang CL, Lin CS. Phytochemical composition, antioxidant activity, and neuroprotective effect of Terminalia chebula Retzius extracts. Evid Based Complement Alternat Med 2012; 2012: 1-7.
[http://dx.doi.org/10.1155/2012/125247] [PMID: 21754945]
[39]
Kumari S, Mythili Krishna J, Joshi AB, et al. A pharmacognostic, phytochemical, and pharmacological review of Terminalia bellerica. J Pharmacogn Phytochem 2017; 6(5): 368-76.
[40]
Keerthana J, Priya AJ, Devi RG. Physiological and pharmacological activities of Terminalia bellerica. Drug Invention Today 2018; 10(10): 2062-6.
[41]
Reddy VNV. Neuroprotective activity of methanolic extract of Terminalia bellerica fruit against aluminium chloride and haloperidol induced amnesia in mice. J Young Pharm 2020; 12.
[42]
Alam S, Ansari S. A brief review of Terminalia bellerica (Balela) with special reference to Unani medicine. Cell Med 2019; 9(3): 5-1.
[43]
Kumar N, Khurana SM. Phytochemistry and medicinal potential of the Terminalia bellirica Roxb. (Bahera). IJNPR 2018; 9(2): 97-107.
[44]
Jain R, Pandey R, Mahant RN, Rathore DS. A review on medicinal importance of Emblica officinalis. Int J Pharm Sci Res 2015; 6(1): 72-84.
[45]
Lanka S. A review on the pharmacological, medicinal, and ethnobotanical important plant: Phyllanthus emblica L. (syn. Emblica officinalis). World J Pharm Res 2018; 7(04): 380-96.
[46]
Hasan MR, Islam MN, Islam MR. Phytochemistry, pharmacological activities and traditional uses of Emblica officinalis: A review. Int Curr Pharm J 2016; 5(2): 14-21.
[http://dx.doi.org/10.3329/icpj.v5i2.26441]
[47]
Rao AN, Priyadarshini K, Satyanarayana T. Anticonvulsant activity of fruit and leaf extract of Emblica officinalis against strychnine induced convulsions in albino mice - a comparative study. Sch Acad J Pharm 2017; 6(12): 536-45.
[48]
Ibn-Baitar. Al-Jamia Al, Al-Advia M, Al-Aghzia WA Urdu Translation by Central Council for Research in Unani Medicine. New Delhi: Ministry of Health & Family Welfare. Govt. of India 1999; pp. 54-6.
[49]
Arzani A. Tib-e-Akbar, Idara Kitab-al-Shifa. New Delhi: YNM 45-52.
[50]
Vakili N, Gorji A. Psychiatry and psychology in medieval Persia. J Clin Psychiatry 2006; 67(12): 1862-9.
[http://dx.doi.org/10.4088/JCP.v67n1205] [PMID: 17194263]
[51]
Khan MYS. Chemical examination of Lavandula stoechas L. Indian J Pharm Sci 1968; 30: 213.
[52]
Ulubelen A, Olcay Y. Triterpenoids from Lavandula stoechas. Fitoterapia 1989; 60: 475-6.
[53]
Hakeem MH, Siddiqui MM, Khan AB. Antiepileptic activity of Ustukhuddus in secondary epilepsy- a case report. Hamdard Med 1991; 34: 33-9.
[54]
Gilani AH, Aziz N, Khan MA, et al. Ethnopharmacological evaluation of the anticonvulsant, sedative and antispasmodic activities of Lavandula stoechas L. J Ethnopharmacol 2000; 71(1-2): 161-7.
[http://dx.doi.org/10.1016/S0378-8741(99)00198-1] [PMID: 10904159]
[55]
Andrieu E, Debussche M. Diaspore removal and potential dispersers of the rare and protected Paeonia officinalis L. (Paeoniaceae) in a changing landscape. Bot J Linn Soc 2007; 154(1): 13-25.
[http://dx.doi.org/10.1111/j.1095-8339.2007.00636.x]
[56]
Drew AJ. Plants and heir Lore. In: Manoy LA, Ed. NJ: Wiccan Formulary and Herbal 2004.
[57]
Rayburn D. Let’s Get Natural with Herbs. Huntsville: Ozark Mountain Publishing 2007.
[58]
Singh MP, Panda H. Medicinal Herbs with their Formulations. Delhi: Daya Publishing House 2005.
[59]
Yousuf S, Atif F, Ahmad M, Ishrat T, Khan B, Islam F. Neuroprotection offered by Majun Khadar, a traditional Unani medicine, during cerebral ischemic damage in rats. Evid Based Complement Alternat Med 2011; 2011: 1-9.
[http://dx.doi.org/10.1093/ecam/nep224] [PMID: 20047892]
[60]
Manolova L. Natural pharmacy Pittsburgh: Dorrance publication 2003.
[61]
Wenzel DG, Haskell AR. Pharmacological actions of Paeonia officinalis. J Am Pharm Assoc (Sci Ed) 1952; 41(3): 162-4.
[http://dx.doi.org/10.1002/jps.3030410317] [PMID: 14927489]
[62]
Tsuda T, Sugaya A, Ohguchi H, Kishida N, Sugaya E. Protective effects of peony root extract and its components on neuron damage in the hippocampus induced by the cobalt focus epilepsy model. Exp Neurol 1997; 146(2): 518-25.
[http://dx.doi.org/10.1006/exnr.1997.6570] [PMID: 9270063]
[63]
Ghani N. Khazāīn-al Advia. New Delhi. Idara Kitab-Al-Shifa. 1971; 1: pp. 942-3.
[64]
Sina I. Alqanun Fil Tib (English translation by Dept of Islamic Studies Jamia Hamdard) Part 2. New Delhi: Hamdard University 1998; pp. 316-7.
[65]
Rushd I. Kitabul Kulliyat. New Delhi: Urdu Translation by CCRUM, Ministry of H & FW, Govt. of India 1987; pp. 299-300.
[66]
Kabiruddin HM. Ilmul Advia Nafeesi. New Delhi: Aijaz Publication 2007; pp. 290-291, 307.
[67]
Zakaria RMB. Kitab-Al-Mansoori (Urdu translation by CCRUM). New Delhi: CCRUM, Ministry of Health and Family Welfare, Govt. of India 1991; pp. 144-5.
[68]
Khan S. Bayaz Khas (Urdu translation by Kabiruddin HM). New Delhi: Aijaz Publishing House 2006; pp. 19-20.
[69]
Duke JA. Handbook of medicinal herbs. (2nd ed.). CRC Press 2002; p. 688.
[http://dx.doi.org/10.1201/9781420040463]
[70]
Usmani A, Khushtar M, Arif M, Siddiqui M, Sing S, Mujahid M. Pharmacognostic and phytopharmacology study of Anacyclus pyrethrum: An insight. J Appl Pharm Sci 2016; 6(03): 144-50.
[http://dx.doi.org/10.7324/JAPS.2016.60325]
[71]
Ibrahim ASB. Kitab Al-Fateh fi Al-Tadawi (Urdu Translation). Delhi: NCPC Printers 2007; p. 174.
[72]
Nabi MG. Makhzan-Al-Mufradat wa Murakabat. (3rd ed.). New Delhi: CCRUM 2007; p. 43.
[73]
Chopra RN, Nayar SL, Chopra IC. Glossary of Indian Medicinal Plants. (7th ed.). New Delhi: CSIR 2002; p. 17.
[74]
Pandey S, Kushwaha GR, Singh A, Singh A. Chemical composition and medicinal uses of Anacyclus pyrethrum. Pharma Sci Monitor 2018; 9(1): 551-60.
[75]
Sharma V, Thakur M, Chauhan NS, Dixit VK. Immunomodulatory activity of petroleum ether extract of Anacyclus pyrethrum. Pharm Biol 2010; 48(11): 1247-54.
[http://dx.doi.org/10.3109/13880201003730642] [PMID: 20843161]
[76]
Sujith K, Ronald Darwin C, Suba V. Antioxidant activity of ethanolic root extract of Anacyclus pyrethrum. Int Res J Pharm 2011; 2(8): 222-6.
[77]
Mandgary A, Sayyah M. Anticonvulsant effect of Anacyclus pyrethrum root extract against experimental seizures. J Iran Biomed 2003; 7(3): 139-43.
[78]
Kalam MA. Evaluation of anticonvulsant activity of Aqer Qerha (Anacyclus pyrethrum DC) root in experimental animals. HJUM 2015; 10: 1-12.

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy